Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Scientific Reports|June 17, 2015
Anchor-based classification and type-C inhibitors for tyrosine kinasesKai-Cheng Hsu, Tzu-Ying Sung, Chih-Ta Lin, et al.Antimicrobial Agents and Chemotherapy|June 25, 2004
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamideChang-Jer Wu, Jia-Tsrong Jan, Chi-Min Chen, et al.Plos One|February 26, 2013
Parallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitorsKai-Cheng Hsu, Hui-Chen Hung, Jim-Tong Horng, et al.Plos One|November 13, 2024
Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase InhibitorsKai-Cheng Hsu, Hui-Chen Hung, Jim-Tong Horng, et al.Antimicrobial Agents and Chemotherapy|September 21, 2011
Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virusJohn T-A Hsu, Jiann-Yih Yeh, Ta-Jen Lin, et al.Oncotarget|November 12, 2016
Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancerHsian-Yu Wang, Yu-Ling Chang, Chun-Chun Cheng, et al.Journal of Medicinal Chemistry|January 15, 2009
Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificityMohane Selvaraj Coumar, Jiun-Shyang Leou, Paritosh Shukla, et al.The Journal of Biological Chemistry|July 27, 2016
Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent MitophagyWan-Ting Tsai, Yin-Chiu Lo, Ming-Sian Wu, et al.Chemmedchem|August 25, 2010
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonistsYi-Hui Peng, Mohane Selvaraj Coumar, Jiun-Shyang Leou, et al.Chemmedchem|November 23, 2012
3D-QSAR-assisted drug design: identification of a potent quinazoline-based Aurora kinase inhibitorYi-Yu Ke, Hui-Yi Shiao, Yung Chang Hsu, et al.Pageof 8